Growth Metrics

Merck (MRK) Retained Earnings (2016 - 2026)

Merck has reported Retained Earnings over the past 18 years, most recently at $66.7 billion for Q1 2026.

  • Quarterly Retained Earnings rose 1443.83% to $66.7 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $66.7 billion through Mar 2026, up 1443.83% year-over-year, with the annual reading at $73.1 billion for FY2025, 1577.76% up from the prior year.
  • Retained Earnings was $66.7 billion for Q1 2026 at Merck, down from $73.1 billion in the prior quarter.
  • Over five years, Retained Earnings peaked at $73.1 billion in Q4 2025 and troughed at -$5.4 billion in Q2 2024.
  • The 5-year median for Retained Earnings is $56.3 billion (2022), against an average of $38.4 billion.
  • Year-over-year, Retained Earnings tumbled 109.89% in 2024 and then skyrocketed 1577.76% in 2025.
  • A 5-year view of Retained Earnings shows it stood at $61.1 billion in 2022, then fell by 11.76% to $53.9 billion in 2023, then crashed by 109.18% to -$4.9 billion in 2024, then soared by 1577.76% to $73.1 billion in 2025, then fell by 8.7% to $66.7 billion in 2026.
  • Per Business Quant, the three most recent readings for MRK's Retained Earnings are $66.7 billion (Q1 2026), $73.1 billion (Q4 2025), and $72.2 billion (Q3 2025).